表皮生长因子受体（EGFR）在炎症性肠病（IBD）相关的肠道癌中表达频繁。 - Suppr

Suppr

超能文献

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer.

作者信息

Svrcek Magali, Cosnes Jacques, Tiret Emmanuel, Bennis Malika, Parc Yann, Fléjou Jean-François

出版信息

Virchows Arch. 2007 Feb;450(2):243-4. doi: 10.1007/s00428-006-0338-7.

DOI:10.1007/s00428-006-0338-7

PMID:17123105

Abstract

摘要

相似文献

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer.

Virchows Arch. 2007 Feb;450(2):243-4. doi: 10.1007/s00428-006-0338-7.

[Clinicopathological features and surgery of intestinal cancer associated with inflammatory bowel disease].

Nihon Rinsho. 2012 Feb;70 Suppl 1:528-34.

Associated neoplastic disease in inflammatory bowel disease.

Surg Clin North Am. 2007 Jun;87(3):659-72. doi: 10.1016/j.suc.2007.03.010.

[Cancer and inflammatory bowel diseases].

Gastroenterol Clin Biol. 2003 Mar;27(3 Suppl):S104-11.

Two cases of hepatoid adenocarcinoma of the intestine in association with inflammatory bowel disease.

Histopathology. 2007 Jul;51(1):123-5. doi: 10.1111/j.1365-2559.2007.02715.x. Epub 2007 May 26.

Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours.

Best Pract Res Clin Gastroenterol. 2008;22(3):537-49. doi: 10.1016/j.bpg.2007.12.001.

Pathology of dysplasia and cancer in inflammatory bowel disease.

Gastroenterol Clin North Am. 2006 Sep;35(3):533-52. doi: 10.1016/j.gtc.2006.07.007.

Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.

Digestion. 2007;75(2-3):113-21. doi: 10.1159/000104731. Epub 2007 Jun 26.

Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer.

Oncogene. 2010 Jun 10;29(23):3313-23. doi: 10.1038/onc.2010.109. Epub 2010 Apr 19.

Cancers complicating inflammatory bowel disease.

N Engl J Med. 2015 Apr 9;372(15):1441-52. doi: 10.1056/NEJMra1403718.

引用本文的文献

Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression.

Cancers (Basel). 2023 May 30;15(11):2970. doi: 10.3390/cancers15112970.

Use of aspirin in the prevention of colorectal cancer through TIGIT-CD155 pathway.

J Cell Mol Med. 2019 Jul;23(7):4514-4522. doi: 10.1111/jcmm.14332. Epub 2019 May 14.

Loss of RHBDF2 results in an early-onset spontaneous murine colitis.

J Leukoc Biol. 2019 Apr;105(4):767-781. doi: 10.1002/JLB.4A0718-283RR. Epub 2019 Jan 29.

Radiographic and endoscopic regression of metastatic gastric cancer to the colon in the setting of 5-aminosalicylic acid use.

J Gastrointest Oncol. 2016 Dec;7(6):E88-E92. doi: 10.21037/jgo.2016.05.02.

Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines.

BMC Cancer. 2016 Feb 19;16:126. doi: 10.1186/s12885-016-2157-9.

An EGFR targeted PET imaging probe for the detection of colonic adenocarcinomas in the setting of colitis.

Theranostics. 2014 Jul 1;4(9):893-903. doi: 10.7150/thno.9425. eCollection 2014.

Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

J Clin Invest. 2012 Aug;122(8):2780-92. doi: 10.1172/JCI62888. Epub 2012 Jul 9.

Colorectal cancer chemoprevention by mesalazine and its derivatives.

J Biomed Biotechnol. 2012;2012:980458. doi: 10.1155/2012/980458. Epub 2012 Jun 4.

CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

World J Gastroenterol. 2009 Jun 21;15(23):2855-61. doi: 10.3748/wjg.15.2855.

Molecular basis of the potential of mesalazine to prevent colorectal cancer.

World J Gastroenterol. 2008 Jul 28;14(28):4434-9. doi: 10.3748/wjg.14.4434.

本文引用的文献

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

J Clin Oncol. 2005 Mar 20;23(9):1803-10. doi: 10.1200/JCO.2005.08.037. Epub 2005 Jan 27.

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025.

Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs.

Eur J Cancer. 2003 Jul;39(10):1348-54. doi: 10.1016/s0959-8049(03)00235-1.

Epidermal growth factor receptor-targeted therapy in colorectal cancer.

Semin Oncol. 2002 Oct;29(5 Suppl 14):10-7. doi: 10.1053/sonc.2002.35643.

Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system.

Cancer. 2001 Sep 1;92(5):1331-46. doi: 10.1002/1097-0142(20010901)92:5<1331::aid-cncr1455>3.0.co;2-m.

Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Dig Dis Sci. 1995 Mar;40(3):485-94. doi: 10.1007/BF02064355.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验